, ECSTRA Team, CRESS UMR 1153, INSERM, 1205.
, Hôpital Barbois, Vandoeuvre-les
International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes, J Clin Oncol, vol.26, pp.4124-4154, 2008. ,
A systematic review and metaanalysis of front-line anthracycline-based chemotherapy regimens for peripheral T-cell lymphoma, ISRN Hematol, vol.623924, p.16, 2011. ,
How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future, Br J Haematol, vol.176, pp.851-66, 2017. ,
Survival of patients with peripheral Tcell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors, J Clin Oncol, vol.31, pp.1970-1976, 2013. ,
Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy, J Clin Oncol, vol.30, pp.631-637, 2012. ,
Brentuximab vedotin in refractory or relapsed peripheral T-cell lymphomas: the French named patient program experience in 56 patients, Haematologica, vol.101, issue.3, pp.103-109, 2015. ,
URL : https://hal.archives-ouvertes.fr/inserm-01419525
Allogeneic hematopoietic cell transplantation for Hodgkin's disease, mantle cell lymphoma and other rare entities: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC), Bull Cancer, vol.104, pp.112-132, 2017. ,
Clinical practice recommendations on indication and timing of hematopoietic cell transplantation in mature T cell and NK/T cell lymphomas: an international collaborative effort on behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation, Biol Blood Marrow Transplant, vol.23, pp.1826-1864, 2017. ,
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers, Ann Oncol, vol.29, pp.715-738, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01759926
The role of autologous stem cell transplantation in patients with nodal peripheral T-cell lymphomas in first complete remission: report from COMPLETE, a prospective, multicenter cohort study, Cancer, vol.29, p.31861, 2019. ,
Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01, J Clin Oncol, vol.30, pp.3093-3102, 2012. ,
Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study, J Clin Oncol, vol.27, pp.106-119, 2009. ,
CAR T-cells for T-cell malignancies: challenges in distinguishing between therapeutic, normal, and neoplastic Tcells, Leukemia, vol.32, pp.2307-2322, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01903063
Graft-versus-T-cell lymphoma effect: a sustained CR after tapering immunosuppressive drugs in a patient with angioimmunoblastic T-cell lymphoma in relapse after allogeneic transplantation, Bone Marrow Transplant, vol.50, pp.304-310, 2015. ,
Graft-versus-lymphoma effect for aggressive T-cell lymphomas in adults: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire, J Clin Oncol, vol.26, pp.2264-71, 2008. ,
Graft-versus-lymphoma effect in relapsed peripheral T-cell non-Hodgkin's lymphomas after reduced-intensity conditioning followed by allogeneic transplantation of hematopoietic cells, J Clin Oncol, vol.22, pp.2172-2178, 2004. ,
Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Societe Francaise de Greffe de Moelle et de Therapie Cellulaire (SFGM-TC), Bone Marrow Transplant, vol.51, pp.358-64, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01299298
Outcomes of related donor HLAidentical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma, Biol Blood Marrow Transplant, vol.19, pp.602-608, 2013. ,
consensus conference on acute GVHD grading, Bone Marrow Transplant, vol.15, pp.825-833, 1994. ,
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma, J Clin Oncol, vol.31, pp.3100-3109, 2013. ,
Peripheral T-cell lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol, vol.108, 2015. ,
Efficacy of high-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphomas as front-line consolidation or in the relapsed/refractory setting: a systematic review/meta-analysis, Biol Blood Marrow Transplant, vol.22, pp.802-816, 2016. ,
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center, Ann Oncol, vol.26, pp.386-92, 2015. ,
Intensified chemo-immunotherapy with or without stem cell transplantation in newly diagnosed patients with peripheral T-cell lymphoma, Leukemia, vol.28, pp.1885-91, 2014. ,
Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma, Ann Oncol, vol.19, pp.958-63, 2008. ,
First-line therapy of T-cell lymphoma: allogeneic or autologous transplantation for consolidation-final results of the AATT study, J Clin Oncol, vol.37, pp.7503-7506, 2019. ,
Allogeneic hematopoietic cell transplant for peripheral T-cell non-Hodgkin lymphoma results in long-term disease control, Leuk Lymphoma, vol.52, pp.1463-73, 2011. ,
Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation, J Clin Oncol, vol.27, pp.3951-3959, 2009. ,
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome, Ann Oncol, vol.22, pp.1608-1621, 2011. ,
Long-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant, Leuk Lymphoma, vol.53, pp.1124-1133, 2012. ,
Allogeneic transplantation following a reducedintensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect, Leukemia, vol.26, pp.520-526, 2012. ,
Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas, Bone Marrow Transplant, vol.47, pp.65-72, 2012. ,
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma, Biol Blood Marrow Transplant, vol.19, pp.1632-1639, 2013. ,
Allogeneic hematopoietic stem cell transplantation (HSCT) for T-cell lymphomas, Blood, vol.26, pp.2018-2019, 2018. ,
Survival following salvage therapy for primary refractory peripheral T-cell lymphomas (PTCL), Am J Hematol, vol.93, pp.394-400, 2018. ,
Efficacy of bendamustine in relapsed/ refractory myeloma patients: results from the French compassionate use program, Leuk Lymphoma, vol.53, pp.632-636, 2012. ,
Oral 5-azacytidine and romidepsin exhibit marked activity in patients with ptcl: a multicenter phase i study, 2019. ,
Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study, J Clin Oncol, vol.29, pp.1182-1191, 2011. ,
Gemcitabine as single agent in pretreated T-cell lymphoma patients: evaluation of the long-term outcome, Ann Oncol, vol.21, pp.860-863, 2010. ,
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis, J Hematol Oncol, vol.12, p.6, 2019. ,
Allogeneic haematopoietic cell transplantation for extranodal natural killer/T-cell lymphoma, nasal type: a CIBMTR analysis, Br J Haematol, vol.182, pp.916-936, 2018. ,
Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma, Blood, vol.132, issue.4, pp.2709-2726, 2017. ,
Reduced-intensity transplantation for lymphomas using haploidentical related donors versus HLA-matched sibling donors: a Center for International Blood and Marrow Transplant Research analysis, J Clin Oncol, vol.34, pp.3141-3150, 2016. ,
Sequential therapy combining clofarabine and T-cell-replete HLA-haploidentical haematopoietic SCT is feasible and shows efficacy in the treatment of refractory or relapsed aggressive lymphoma, Bone Marrow Transplant, vol.50, pp.679-84, 2015. ,
Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/ refractory CD30 positive lympho-proliferative disorders: a single centre experience, Intern Med J, vol.47, pp.574-582, 2017. ,
Successful use of brentuximab vedotin for refractory anaplastic large cell lymphoma as a bridging therapy to haploidentical stem cell transplantation and maintenance therapy posttransplantation, Pediatr Blood Cancer, vol.62, pp.1063-1068, 2015. ,
, Publisher's Note
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations